M&A Deal Summary |
|
---|---|
Date | 2021-11-22 |
Target | Abveris |
Sector | Life Science |
Buyer(s) | Twist Bioscience |
Deal Type | Add-on Acquisition |
Deal Value | 190M USD |
Advisor(s) | Edgemont Capital Partners LP (Financial) Nutter McClennen & Fish (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2013 |
Sector | Life Science |
Employees | 919 |
Revenue | 245M USD (2023) |
Twist Bioscience has developed a proprietary semiconductor-based synthetic DNA manufacturing process featuring a 10,000-well silicon platform capable of producing synthetic biology tools, such as oligonucleotides, genes, pathways, chassis, and genomes. By synthesizing DNA on silicon instead of on traditional 96-well plastic plates, our platform overcomes the current inefficiencies of synthetic DNA production, and enables cost-effective, rapid, high-quality, and high throughput synthetic gene production. Twist Bioscience was founded in 2013 and is based in San Francisco, California.
DEAL STATS | # |
---|---|
Overall | 3 of 3 |
Sector (Life Science) | 2 of 2 |
Type (Add-on Acquisition) | 3 of 3 |
State (Massachusetts) | 1 of 1 |
Country (United States) | 3 of 3 |
Year (2021) | 2 of 2 |
Size (of disclosed) | 1 of 2 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-06-30 |
iGenomX
Carlsbad, California, United States iGenomX company offers multiplex library preparation tools for next-generation sequencing (NGS) workflows. iGenomX develops and commercializes a high-throughput rapid library preparation that facilitates large sample volume with a simple workflow at enabling price points. The resulting commercial library construction maximizes laboratory capacity for many applications including population genetics, agrigenomics, microbiome, and synthetic biology. iGenomX was founded in 2012 and is based in Carlsbad, California. |
Buy | $35M |